COVID a mixed bag for Japan's medical and sanitary goods companies

Test kit makers see sales jump while pharmaceuticals struggle

AKANE OKUTSU, Nikkei staff writer

TOKYO -- The yearlong COVID-19 pandemic presented a mixed picture for medical and sanitary goods makers in Japan, as earnings results from companies such as Unicharm, Takara Bio and big drugmakers revealed last week.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.